Richard Taylor, MD
Hospice and Palliative Medicine · Jacksonville, FLNPI 1235561259
Payments from drug & device makers
What this record shows
This record is dominated by education: $200 of the $303 with a category attached, or 66.0%. 5 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 33.0% of the total. Reporting peaked in 2019 at $230 and has fallen 92.7% since, to $17 in 2021.
Across 5 payments — averaging $60.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$100
- Genentech USA, Inc.$100
- Eisai Inc.$55
- Abbott$30
- Gilead$17
What the payments were for
- Food & beverage$10334%
- Education$20066%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $100 |
| Genentech USA, Inc. | 1 | $100 |
| Eisai Inc. | 1 | $55 |
| Abbott | 1 | $30 |
| Gilead | 1 | $17 |
How this compares
$303 in reported general payments places this provider in the 80th percentile of 177 hospice and palliative medicine providers in Florida.
See all hospice and palliative medicine providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 15 | $16,293 |
| Fentanyl | 102 | $8,116 |
| Modafinil | 12 | $4,806 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 26 | $3,620 |
| Oxycodone Hcl | 144 | $2,528 |
| Pregabalin | 115 | $2,081 |
| Olanzapine | 68 | $1,378 |
| Hydromorphone Hcl | 43 | $751 |
| Morphine Sulfate ErMorphine Sulfate | 24 | $524 |
| Gabapentin | 15 | $502 |
| Duloxetine Hcl | 33 | $472 |
| Dexamethasone | 35 | $437 |
| Morphine Sulfate | 14 | $381 |
| Methadone Hcl | 16 | $302 |
| Lorazepam | 25 | $202 |
Paid to pharmacies, not to this prescriber.
Other hospice and palliative medicine in Jacksonville
- Zaheera LukmanJacksonville$171
- Laurence PettyPlant City$140K
- Michael KaragiozisTemple Terrace$21K
- Young Doo ChangTampa$10K
- Joshua SmithTampa$7K
- Sharon Nickell-OlmEustis$3K
- Lidia OliveiraLake Mary$2K
- William BerkeNorth Miami Beach$2K
- Anthony DardanoBoca Raton$2K
- Diane PortmanTampa$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.